ALBT — Avalon GloboCare Corp.
NASDAQ · Real Estate · Real Estate Services
$0.28
+$0.00 (+0.00%)
Avalon GloboCare Corp. (ALBT) is a real estate services company listed on NASDAQ. It is led by David K. Jin M.D., Ph.D., based in 4400 Route 9 South, Freehold, NJ, United States, 07728, with about 4 employees. Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States. It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the AI Nutritionist software program that helps users monitor and manage ketogenic diet and related programs. Avalon GloboCare Corp. was founded in 2015 and is headquartered in Freehold, New Jersey.
Latest reported ALBT revenue for 2025-09-30 was $350.1K. Net income was -$254.3K. Revenue was down 0.1% from 2025-06-30 to 2025-09-30. ALBT currently screens at market cap $5.9M.
Use this ALBT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ALBT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ALBT SEC filings page. Lician reads the product cache first so this HTML stays unique to Avalon GloboCare Corp. even when a live quote feed is slow.
About Avalon GloboCare Corp.
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States. It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the AI Nutritionist software program that helps users monitor and manage ketogenic diet and related programs. Avalon GloboCare Corp. was founded in 2015 and is headquartered in Freehold, New Jersey.
ALBT Key Statistics
Market Cap
$5.93M
Volume
9.30M
Previous Close
$0.28
Day Range
$0.26 – $0.31
EPS
-$8.44
Revenue
$1.33M
Net Income
-$7.90M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+6.2%
Profit Margin
-592.7%
Employees
4
ALBT Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $1.33M | $1.26M | $1.20M | $1.39M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$7.90M | -$16.71M | -$11.93M | -$9.09M |
| EPS (Diluted) | -$8.44 | -$23.80 | -$1.28 | -$1.07 |
Total Assets
$20.99M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$2.86M
Operating Cash Flow
-$4.97M
Free Cash Flow
$0.00
Avalon GloboCare Corp. Company Information
- CEO, President & Director
- David K. Jin M.D., Ph.D.
- Headquarters
- 4400 Route 9 South, Freehold, NJ, United States, 07728
- Website
- www.avalon-globocare.com
- Phone
- 732 780 4400
- IPO / Founded
- 2016-12-06
- Sector
- Real Estate
- Industry
- Real Estate Services